This rapid risk assessment (RRA) addresses the risk of importation of Rift Valley fever (RVF) virus (RVFV) and further spread of the virus within the European Union/European Economic Area (EU/EEA) in relation to the recent increase in cases reported on Mayotte, France.
This rapid risk assessment addresses the public health risk associated with the early occurrence of a large number of West Nile virus infections in the EU/EEA and EU neighbouring countries in 2018.
This rapid risk assessment monitors the threat posed by Rift Valley fever (RVF) which has been reported in regions of eastern and southern Africa, and in most of the sub-Saharan and West African countries.
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
ECDC and EFSA have assessed the risk to the EU/EEA posed by a fatal human case of Bacillus anthracis infection in Bulgaria and concluded that this event represents a negligible risk to other EU/EEA countries.
The recent floods in Bosnia and Herzegovina, Croatia, and Serbia caused substantial damage. Following the floods, there is a risk of increased transmission of vector-borne infections to the populations.
West Nile virus (WNV) is an emerging pathogen whose ecology and epidemiology extend across multiple interfaces. As the epidemiology and transmission cycle of WNV is complex, assessing the risk of WNV being transmitted to humans is not always straightforward. Therefore, the WNV risk assessment tool has been developed to provide operational guidance in support of the risk assessment process.
Within the context of the West Nile virus outbreaks, an ECDC mission was conducted at the end of the transmission season to support the Greek authorities regarding further response and prevention activities on West Nile virus infections.
This is an update to the joint rapid risk assessment published on 6 July 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to further cases in France and Denmark. It contains information updated up to the 13 July 2012.
On 7 and 10 July, the Hellenic Centre for Disease Control and Prevention (KEELPNO) reported the first two human cases of West Nile virus (WNV) infection in Greece this year. When looking at the epidemiology of WNV infection in Greece since 2010, one can observe a progressive geographical expansion of WNV transmission throughout the country. For this reason, these newly confirmed cases in Athens do not come unexpected.